16 August 2024
16 August 2024
The funding will support the company's commercial expansion plan as well as the initiation of the BOOMBOX Master Study.
Following a trial alongside the US Department of Defense, the haemostatic gel has been cleared for use with moderate to severe bleeding.
Esopredict analyses a patient’s DNA methylation levels which generates a personalised risk score of how likely they are to progress to cancer.
The Vascade MVP XL system provides a larger disc and 58% more collagen than its predecessor, the Vascade MVP system.
Sales of Medtronic’s existing diabetes care devices have been declining due to a competitive market.
Exact claims its Cologuard test has contributed towards $22bn savings in the US healthcare system since its FDA approval in 2014.
The trial aims to secure US Food and Drug Administration (FDA) premarket approval for the Signal-C colorectal cancer screening blood test.
The financing round was led by new investors Prosegur, Export Development Canada and Azahar.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
